EMEA-000035-PIP02-09-M02

Key facts

Active substance
Tiotropium bromide (monohydrate)
Therapeutic area
Pneumology-allergology
Decision number
P/0005/2015
PIP number
EMEA-000035-PIP02-09-M02
Pharmaceutical form(s)
  • Inhalation solution
  • Inhalation powder
  • Capsule, hard
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Inhalation use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132 778271
Email: paediatrics@boehringer-ingelheim.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000035-PIP02-09-M02
Compliance opinion date
27/05/2016
Compliance outcome
positive

Decision

How useful was this page?

Add your rating